Most recently, it's been recognized that conolidine and the above derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent locations as classical opioid receptors, it binds to a big range of endogenous opioids. Contrary to most opioid receptors, this receptor functions like a scavenger and would not activate a 2nd me